BRIEF-Aprea Therapeutics Announces Agreement With MD Anderson Cancer Center To Explore Apr-1051 As A Potential Treatment For Head And Neck Squamous Cell Carcinoma (Hnscc)

Reuters
11 Mar
BRIEF-Aprea <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announces Agreement With MD Anderson Cancer Center To Explore Apr-1051 As A Potential Treatment For Head And Neck Squamous Cell Carcinoma (Hnscc)

March 11 (Reuters) - Aprea Therapeutics Inc APRE.O:

  • APREA THERAPEUTICS ANNOUNCES AGREEMENT WITH MD ANDERSON CANCER CENTER TO EXPLORE APR-1051 AS A POTENTIAL TREATMENT FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)

  • APREA THERAPEUTICS: UNDER TERMS OF AGREEMENT, APREA WILL RETAIN ALL RIGHTS, TITLE, AND INTEREST IN APR-1051

Source text: ID:nGNXb4FmxN

Further company coverage: APRE.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10